Healthcare supply chains have faced significant stress tests in recent years. From the pandemic and geopolitical shocks to labor shortages and inflation, certain lessons are now impossible to ignore if health systems want to remain resilient and clinically effective.
Many opportunities exist in 2026 for supply chain leaders to transform both the bottom line and clinical operations if they embrace the coming change. In addition, artificial intelligence (AI’s) influence on supply chain operations stands to deliver significant positive impact if health systems consider smart investments and implementations that can help circumvent disruptions.
From changing supplier models and tighter alignment with clinical operations to data-driven decision making and predictive analytics, supply chain executives who acknowledge key lessons and embrace change will best position their organizations for the future of supply chain optimization
Data-Driven Decision Making is Non-Negotiable
Healthcare supply chains have struggled with visibility into data for years, but two recent occurrences have created renewed urgency for overcoming this challenge: COVID and the introduction of tariffs. Supply chain leaders continue to lack critical insights into country of origin data and raw materials—both needed for effective response when disruptions like these occur. Unfortunately, many existing systems also lack end-to-end visibility into secondary suppliers, inventory across multiple sites and consumption at the point of care.
In 2026, supply chain leaders must acknowledge that reliance on manual spreadsheets and siloed ERP systems will not lay the needed foundation for proactive response to ongoing challenges. Investments in tools that bring together critical information for real-time tracking and the ability to drill down in granular, multi-faceted data such as cost per case by physician and procedure will be critical to improving costs and clinical outcomes.
Cost Optimization and Resiliency are Not Complementary
By nature, cost optimization and resiliency have conflicting goals in healthcare supply chains. Cost optimization prioritizes standardization around the greatest value, while resiliency focuses more on readiness for disruption. Consequently, supply chain leaders that lean into one of these areas more heavily are facing one of two results: lack of options when shortages present or costs spiraling out of control.
Success going forward will necessitate a balanced approach to each area—eliminating variation to improve costs while refining supplier strategies to ensure resiliency. For example, many forward-thinking health systems will look to more domestic sourcing in 2026 to reduce the potential for disruptions related to geo-political risks.
Supplier Relationships Matter
The last few years have certainly brought the importance of supplier relationships into focus, especially as it pertains to understanding tariff risk and overcoming supply shortages. Heading into 2026, supply chain leaders should brace for tough negotiations with suppliers as many will use tariff disruptions as an opportunity to raise prices.
Readiness will be key to minimizing bottom-line impact and ensuring resiliency in 2026 and beyond. Consequently, health systems that have relied on traditional GPO and supplier partnerships must evolve their strategy. Decades-old approaches that prioritize quantity over value are shifting, and new models prioritize long-term, stable relationships with a few suppliers, allowing for greater collaboration and exploration of quality levers far beyond price points.
Supply Chain Alignment with Clinical is Imperative
Achieving clinician buy-in around standardization and reducing waste is in the best interest of all stakeholders, but as the reach of value-based contracting increases, it will be critical to success. Data plays an important role in aligning the interests of supply chain with clinicians.
When supply chain executives have access to the right data to back up a claim, they can work collaboratively with clinicians to standardize supply choices around those that produce the best patient outcomes and cost efficiencies.
The Power of AI in Supply Chain Cannot Be Ignored
Use of AI in supply chain operations is advancing rapidly in many industries. In healthcare, supply chain leaders have been more cautious with AI because so much is at stake from a patient safety standpoint. In 2026, the industry will see a shift in adoption of AI as these capabilities become more mainstream in ERP and EHR systems.
Simply put, supply chain leaders who put their head in the sand will be left behind. AI will increasingly be used to analyze large datasets to reduce both shortfalls and excess inventory, improving resilience when sudden demand shifts occur. Notably, AI is poised to have the greatest impact on compressing the cycle time from question → insight → action from a supply chain perspective.
Moving from Lessons Learned to Optimization
As healthcare organizations look ahead to 2026, the message for supply chain leaders is clear: resilience, cost stewardship and clinical excellence can no longer be pursued in isolation. The lessons of recent years underscore the need for better data, stronger supplier partnerships, closer clinical alignment and thoughtful adoption of advanced technologies like AI.
Those who embrace the need for change will not only be better prepared for disruption, but will also create measurable value for patients, clinicians and the enterprise.
